» Articles » PMID: 18434559

Evaluation of Eight Anti-rubella Virus Immunoglobulin G Immunoassays That Report Results in International Units Per Milliliter

Overview
Specialty Microbiology
Date 2008 Apr 25
PMID 18434559
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

An evaluation of anti-rubella virus immunoglobulin G (IgG) immunoassays that report in international units per milliliter (IU/ml) was performed to determine their analytical performance and the degree of correlation of the test results. A total of 321 samples were characterized based on results from a hemagglutination inhibition assay. The 48 negative and 273 positive samples were used to determine the sensitivity and specificity of the assays. When equivocal results were interpreted as reactive, the sensitivity of the immunoassays ranged from 98.9 to 99.9% and the specificity ranged from 77.1 to 95.8%. All assays had positive and negative delta values of less than 2. A significant difference between the mean results of all assays was demonstrated by analysis of variance. However, post hoc analysis showed there was good correlation in the mean results expressed in IU/ml between some of the assays. Our results show the level of standardization between anti-rubella virus IgG immunoassays reporting results expressed as IU/ml has improved since a previous study in 1992, but further improvement is required.

Citing Articles

Serosurveillance for Measles and Rubella.

Brady A, El-Badry E, Padron-Regalado E, Escudero Gonzalez N, Joo D, Rota P Vaccines (Basel). 2024; 12(7).

PMID: 39066453 PMC: 11281569. DOI: 10.3390/vaccines12070816.


The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases.

Dimech W Clin Microbiol Rev. 2021; 34(4):e0003521.

PMID: 34319148 PMC: 8404693. DOI: 10.1128/CMR.00035-21.


Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods.

English E, Cook L, Piec I, Dervisevic S, Fraser W, John W J Clin Microbiol. 2021; 59(9):e0028821.

PMID: 34260272 PMC: 8373017. DOI: 10.1128/JCM.00288-21.


Estimating the immunogenicity of measles-rubella vaccination administered during a mass campaign in Lao People's Democratic Republic using multi-valent seroprevalence data.

Vynnycky E, Miyano S, Komase K, Mori Y, Takeda M, Kitamura T Sci Rep. 2019; 9(1):12545.

PMID: 31467441 PMC: 6715652. DOI: 10.1038/s41598-019-49018-y.


Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.

Hayford K, Mutembo S, Carcelen A, Matakala H, Munachoonga P, Winter A Vaccine. 2019; 37(17):2387-2393.

PMID: 30905529 PMC: 6467544. DOI: 10.1016/j.vaccine.2019.02.037.


References
1.
Owen W, Martins T, Litwin C, Roberts W . Performance characteristics of six IMMULITE 2000 TORCH assays. Am J Clin Pathol. 2006; 126(6):900-5. DOI: 10.1309/KUA926D3YAPFYQG8. View

2.
Nedeljkovic J, Jovanovic T, Mladjenovic S, Hedman K, Peitsaro N, Oker-Blom C . Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells. J Clin Virol. 1999; 14(2):119-31. DOI: 10.1016/s1386-6532(99)00048-7. View

3.
Dati F . An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur Immunoassay System. Clin Lab. 2004; 50(1-2):53-61. View

4.
Francis B, Thomas A, McCarty C . The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia. Am J Public Health. 2003; 93(8):1274-6. PMC: 1447953. DOI: 10.2105/ajph.93.8.1274. View

5.
Steece R, Talley M, Skeels M, Lanier G . Comparison of enzyme-linked immunosorbent assay, hemagglutination inhibition, and passive latex agglutination for determination of rubella immune status. J Clin Microbiol. 1985; 21(1):140-2. PMC: 271594. DOI: 10.1128/jcm.21.1.140-142.1985. View